BIO.AU Biome Australia Ltd
- Market cap
- AUD 83.3M
- P/E
- 18.0x
- P/B
- 8.88x
- ROE
- 38.5%
- Dividend yield
- -
- Fundamental score
- 2.3/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is BIO.AU undervalued?
Graham numberBIO.AU trades 166.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Biome Australia Ltd fundamental analysis
10 of 22 checks passedROE 2/2
High return on equity (38.5%), above 20%.
ROA 1/1
Return on assets (23.0%) is above the industry median (-51.4%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (1,516.3%) is above the industry median (-5.3%).
Revenue Growth 2/2
Revenue grew 48.9% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (31.6%), 40% or less.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 15.7x against interest expense, well covered.
PE vs Market 0/1
PE (18.0x) is above the market median (15.0x).
PE vs Industry 0/1
PE (18.0x) is above the industry median (16.3x).
PBV 0/1
Price to book (8.9x) is above the industry median (4.4x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 159.9, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Biome Australia Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Biome Australia Ltd
Biome Australia Limited engages in the development, commercialization, and marketing of live biotherapeutics and complementary medicines in Australia and internationally. It provides its products under the Activated Probiotics and Activated Therapeutics brand names. The company's products are used to support the management of low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. It markets its products through community pharmacies, independent health pra…
Full company profileBiome Australia Ltd financial statements
Biome Australia Ltd annual financial statements
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 387K | 866K | 2.32M | 4.11M | 7.24M | 13.0M | 18.4M | 23.9M |
| Gross Profit | 221K | 231K | 1.07M | 2.38M | 4.06M | 7.91M | 11.3M | 6.74M |
| Operating Income | -1.90M | -2.61M | -5.52M | -4.21M | -3.28M | -1.67M | 278K | 1.80M |
| EBITDA | 1.05K | -3.25M | -5.39M | -4.65M | -3.15M | -1.58M | 242K | 2.15M |
| Net Income | -2.01M | -3.16M | -5.38M | -4.54M | -3.08M | -1.67M | 215K | 3.61M |
| EPS | -0.01 | -0.02 | -0.03 | -0.02 | -0.02 | -0.01 | 0.00 | 0.02 |
| Balance Sheet | ||||||||
| Total Assets | 1.82M | 1.95M | 11.1M | 8.25M | 7.56M | 8.28M | 12.0M | 15.7M |
| Total Liabilities | 611K | 997K | 920K | 1.73M | 3.97M | 5.37M | 7.29M | 6.34M |
| Shareholders' Equity | 1.20M | 950K | 10.2M | 6.53M | 3.59M | 2.90M | 4.68M | 9.38M |
| Cash & Short-term Investments | 480K | 474K | 635K | 5.49M | 2.26M | 2.87M | 2.75M | 3.55M |
| Total Debt | 42.3K | 505K | 81.0K | 467K | 1.15M | 1.30M | 3.07M | 2.97M |
| Cash Flow | ||||||||
| Operating Cash Flow | -2.13M | -3.22M | -2.39M | -3.42M | -3.50M | -164K | -2.82M | 1.63M |
| Capital Expenditure | 520K | 180K | 67.8K | 128K | 401K | 21.6K | 37.1K | 204K |
| Free Cash Flow | -2.65M | -3.40M | -2.46M | -3.55M | -3.90M | -185K | -2.86M | 1.42M |
| Ratios | ||||||||
| ROE | -167.0% | -333.0% | -52.9% | -69.6% | -85.8% | -57.5% | 4.6% | 38.5% |
| ROA | -110.8% | -162.4% | -48.5% | -55.0% | -40.7% | -20.2% | 1.8% | 23.0% |
| Net Profit Margin | -520.4% | -365.1% | -232.1% | -110.4% | -42.5% | -12.8% | 1.2% | 15.1% |
| Debt to Equity | 0.04x | 0.53x | 0.01x | 0.07x | 0.32x | 0.45x | 0.66x | 0.32x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Biome Australia Ltd dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | AUD 170K | 0.00 | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Biome Australia Ltd
- Insiders 36.01%
- Institutions 1.03%
- Public & others 62.96%
- Shares outstanding 231M
- Free float 162M
Biome Australia Ltd company profile
- Company name
- Biome Australia Ltd
- Ticker
- BIO.AU
- ISIN
- AU0000184137
- Exchange
- Australian Securities Exchange
- Sector
- Consumer Defensive
- Industry
- Biotechnology
- Fiscal year end
- June
- Address
- 192-194 Johnston Street, Collingwood, VIC, Australia, 3066
- Phone
- 61 3 9017 5800
- Website
- biomeaustralia.com
About Biome Australia Ltd
Biome Australia Limited engages in the development, commercialization, and marketing of live biotherapeutics and complementary medicines in Australia and internationally. It provides its products under the Activated Probiotics and Activated Therapeutics brand names. The company's products are used to support the management of low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2018 and is based in Collingwood, Australia.
Biome Australia Ltd management
4- Mr. Blair William Brabin Vega NorfolkMD, CEO & Director · born 1985
- Ms. Lauren DwyerChief Financial Officer
- Dr. Jaroslav Haman BoublikChief Science Officer & Member of Scientific Advisory Board
- Mr. George Lazarou ACA, BComCompany Secretary